Literature DB >> 31874237

Recent trends in cell membrane-cloaked nanoparticles for therapeutic applications.

Bogyu Choi1, Wooram Park1, Sung-Bin Park1, Won-Kyu Rhim2, Dong Keun Han3.   

Abstract

Synthetic nanoparticles are extensively utilized in various biomedical engineering fields because of their unique physicochemical properties. However, their exogenous characteristics result in synthetic nanosystem invaders that easily induce the passive immune clearance mechanism, thereby increasing the retention effect caused by reticuloendothelial system (RES), resulting in low therapeutic efficacy and toxic effects. Recently, a cell membrane cloaking has been emerging technique as a novel interfacing approach from the biological/immunological perspective. This has been considered as useful technique for improving the performance of synthetic nanocarriers in vivo. By cell membrane cloaking, nanoparticles acquire the biological functions of natural cell membranes due to the presence of membrane-anchored proteins, antigens, and immunological moieties as well as physicochemical property of natural cell membrane. Due to cell membrane cloaking, the derived biological properties and functions of nanoparticles such as their immunosuppressive capability, long circulation time, and disease targeting ability have enhanced their future potential in biomedicine. Here, we review the cell membrane-cloaked nanosystems, highlight their novelty, introduce the preparation and characterization methods with relevant biomedical applications, and describe the prospects for using this novel biomimetic system that was developed from a combination of cell membranes and synthetic nanomaterials.
Copyright © 2019 Elsevier Inc. All rights reserved.

Keywords:  Biomedical applications; Biomimetic; Cell membrane; Nanoparticle; Therapy

Mesh:

Substances:

Year:  2019        PMID: 31874237     DOI: 10.1016/j.ymeth.2019.12.004

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  8 in total

Review 1.  Platelets for cancer treatment and drug delivery.

Authors:  Gaozhe Xiao; Zhikun Zhang; Qiaoying Chen; Tao Wu; Wei Shi; Lu Gan; Xiuli Liu; Yong Huang; Mengyu Lv; Yongxiang Zhao; Pan Wu; Liping Zhong; Jian He
Journal:  Clin Transl Oncol       Date:  2022-02-26       Impact factor: 3.405

2.  Platelet-Membrane-Encapsulated Carvedilol with Improved Targeting Ability for Relieving Myocardial Ischemia-Reperfusion Injury.

Authors:  Tingting Zhou; Xuechao Yang; Tianyi Wang; Mingming Xu; Zhanghao Huang; Runze Yu; Yi Jiang; Youlang Zhou; Jiahai Shi
Journal:  Membranes (Basel)       Date:  2022-06-10

3.  Erythrocyte membrane-camouflaged nanoparticles as effective and biocompatible platform: Either autologous or allogeneic erythrocyte-derived.

Authors:  Jun Dai; Zhaojun Chen; Shixuan Wang; Fan Xia; Xiaoding Lou
Journal:  Mater Today Bio       Date:  2022-05-05

Review 4.  Membrane-Coated Biomimetic Nanoparticles: A State-of-the-Art Multifunctional Weapon for Tumor Immunotherapy.

Authors:  Yuanyuan Zhang; Xinyi Zhang; Haitao Li; Jianyong Liu; Wei Wei; Jie Gao
Journal:  Membranes (Basel)       Date:  2022-07-28

5.  Targeted Diagnosis, Therapeutic Monitoring, and Assessment of Atherosclerosis Based on Mesoporous Silica Nanoparticles Coated with cRGD-Platelets.

Authors:  Wei Zhang; Zheng Lv; Yupeng Zhang; Subash C B Gopinath; Yi Yuan; Deyou Huang; Liu Miao
Journal:  Oxid Med Cell Longev       Date:  2022-09-29       Impact factor: 7.310

6.  Platelet membrane-camouflaged nanoparticles carry microRNA inhibitor against myocardial ischaemia‒reperfusion injury.

Authors:  Tianyi Wang; Tingting Zhou; Mingming Xu; Shuo Wang; Anqi Wu; Mingyang Zhang; You Lang Zhou; Jiahai Shi
Journal:  J Nanobiotechnology       Date:  2022-10-04       Impact factor: 9.429

7.  Recent advances in cell membrane-camouflaged nanoparticles for inflammation therapy.

Authors:  Rongtao Zhang; Siqiong Wu; Qian Ding; Qingze Fan; Yan Dai; Shiwei Guo; Yun Ye; Chunhong Li; Meiling Zhou
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

Review 8.  Recent progress in targeted delivery vectors based on biomimetic nanoparticles.

Authors:  Li Chen; Weiqi Hong; Wenyan Ren; Ting Xu; Zhiyong Qian; Zhiyao He
Journal:  Signal Transduct Target Ther       Date:  2021-06-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.